Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Interest Expenses (2020 - 2024)

Gyre Therapeutics (GYRE) has disclosed Interest Expenses for 9 consecutive years, with $315000.0 as the latest value for Q1 2024.

  • Quarterly Interest Expenses fell 51.01% to $315000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $315000.0 through Dec 2024, down 51.01% year-over-year, with the annual reading at $2.6 million for FY2023, 88.79% up from the prior year.
  • Interest Expenses for Q1 2024 was $315000.0 at Gyre Therapeutics, down from $643000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $643000.0 in Q1 2023, with the low at $7000.0 in Q3 2020.
  • Average Interest Expenses over 3 years is $253750.0, with a median of $182500.0 recorded in 2020.
  • Peak annual rise in Interest Expenses hit 51.01% in 2024, while the deepest fall reached 51.01% in 2024.
  • Over 3 years, Interest Expenses stood at $50000.0 in 2020, then surged by 1186.0% to $643000.0 in 2023, then crashed by 51.01% to $315000.0 in 2024.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $315000.0, $643000.0, and $50000.0 for Q1 2024, Q1 2023, and Q4 2020 respectively.